![Comparison of aciclovir, famciclovir and valaciclovir for management of herpes simplex and herpes zoster infections | Semantic Scholar Comparison of aciclovir, famciclovir and valaciclovir for management of herpes simplex and herpes zoster infections | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ee4838eeadc024a4283a7294d32229e2c0497665/2-Table1-1.png)
Comparison of aciclovir, famciclovir and valaciclovir for management of herpes simplex and herpes zoster infections | Semantic Scholar
![Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials - The Lancet Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials - The Lancet](https://www.thelancet.com/cms/attachment/a6e04134-5021-4c69-8936-add20f5e935d/gr1.gif)
Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials - The Lancet
![Management of Acyclovir-Resistant Herpes Simplex Virus Infection in Patients Undergoing Hematopoietic Stem-Cell Transplantation Management of Acyclovir-Resistant Herpes Simplex Virus Infection in Patients Undergoing Hematopoietic Stem-Cell Transplantation](https://jhoponline.com/images/jhop/2021/August/Management_table.jpg)
Management of Acyclovir-Resistant Herpes Simplex Virus Infection in Patients Undergoing Hematopoietic Stem-Cell Transplantation
![Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials - The Lancet Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials - The Lancet](https://www.thelancet.com/cms/attachment/6a36b6d1-7069-4f30-aee2-808139178a60/gr2_lrg.jpg)